In summary, we collected and analyzed the genomic alteration of MET in 5,008 lung cancer cases and reported the accurate incidence of MET exon 14 skipping mutation and MET amplification and their correlations with clinicopathological features in patients from east China. Here, MET is linked to lung cancer.